source
- Ultragenyx to cut 20% of staff and halve R&D budget as it pivots to commercial salesUltragenyx announced it will reduce its workforce by about 20%, bringing headcount down to roughly 1,000 employees. The cuts follow an earlier 10% reduction announced in February and are part of a…
- Bernie Sanders poised to steer FDA user fee renewal, could push for reformsDemocrats' midterm victory may shape the upcoming negotiations on the Prescription Drug User Fee Act, which funds the FDA's review of medicines. Senator Bernie Sanders, a longtime critic of the us…